Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ISRCTN43870533) titled 'A study to assess the safety, tolerability, and preliminary effects of a single injection of BC-015 in adults with lipid disorders- Part 2' on Oct. 18.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Safety, efficacy, preliminary efficacy
Primary Sponsor: BaseCure Therapeutics Inc.
Condition:
Hypercholesterolemia
Circulatory System
Intervention:
This is a Phase 1b/2a, randomized, single-blind, placebo-controlled study of BC-015, given as a single injection under the skin to adults with high choles...